New cancer drug leads to 100% remission

Dr. Luis Diaz of Memorial Sloan Kettering Cancer Center was just on CNN and talked about a new immunotherapy drug that provided complete tumor remission to 18 patients of their colorectal cancer tumors. He of course wants more patients and more trials, but also stated he wants to also look into more cancers including PC. My best to all.

Also the CDC just authorized $250 million for the cancer moonshot initiative to cut cancer related deaths by 50% and $ 1 billion over the next 5 years to help cancer survivors.

I just listened to more of the interview and the immunotherapy is done before surgery or radiation to replace them and their SEs.
Jack

Citing the link below mainly because of one sentence in it, which confirms what Jack64 said:

"Doctors, stunned with the effectiveness of the drug, are now expanding the trial to include gastric, prostate, and pancreatic cancer patients." (Boldface mine).

And a few other quotes from the link:

"Normally, just a 500mg dose of the drug, administered intravenously over a 30-minute period, is effective."

"Surprisingly, at the 12-month follow up, all the tumours had seemingly disappeared from their bodies ... This is the first time this has happened in the history of cancer … it’s really exciting."

Of course, naturally and appropriately, the article ends with

"However, despite the groundbreaking results, doctors and researchers insist on larger studies to ascertain the complete clinical effects of dostarlimab."

Clearly it's much too early to start getting excited that this drug is the magic bullet. The history of cancer research is littered with the names of drugs that showed great promise at first, but then fell to the wayside as further work revealed their shortcomings.

But one can always hope.

Maybe in a year or so we'll have a better idea about that.

https://www.healthcareasia.org/2022/complete-cancer-remission-in-drug-trial-development/#:~:text=doctors%2c%20stunned%20with%20the%20effectiveness%20of%20the%20drug%2c,immune%20system%20to%20recognise%20and%20destroy%20these%20cells.

I am surprised that nobody has come up with a targeted immunotherapy that would target PSA.

All 18 had something called dna mismatch repair (dmmr) variant in the tumor’s genetics and the drug apparently works wonders for those whose tumors have that trait.

Its relatively rare in colon cancers but if you have it, this looks really good!

Any day the critters get beat is a good day.